Dissolution efficiency and bioequivalence study using urine data from healthy volunteers: a comparison between two tablet formulations of cephalexin

Authors

  • Cristina Helena dos Reis Serra Universidade de São Paulo; Department of Pharmacy
  • Kyung Hee Chang Libbs
  • Thaisa Marinho Dezani Universidade de São Paulo; Department of Pharmacy
  • Valentina Porta Universidade de São Paulo; Department of Pharmacy
  • Sílvia Storpirtis Universidade de São Paulo; Department of Pharmacy

DOI:

https://doi.org/10.1590/S1984-82502015000200016

Abstract

;The aim of the present study was to assess the bioequivalence of two cephalexin tablet formulations available in the Brazilian market (product A as reference formulation and product B as test formulation). Dissolution efficiency (DE%) was calculated for both formulations to evaluate their;in vitro;biopharmaceutical features. The oral bioequivalence study was performed in twenty-four healthy volunteers in a crossover design. Single oral dose (tablet containing 500 mg of cephalexin) of each product was administered with two weeks of washout period. Urinary concentrations of cephalexin were measured by high-performance liquid chromatography (HPLC) method and pharmacokinetics parameters were estimated by urinary excretion data. The bioequivalence was determined by the following parameters: the cumulative amount of cephalexin excreted in the urine, the total amount of cephalexin excreted in the urine and the maximum urinary excretion rate of cephalexin. DE values of immediate-release cephalexin tablets (500 mg) were 68.69±4.18% for product A and 71.03±6.63% for product B. Regarding the dissolution test of the two brands (A and B) analysed, both were in compliance with the official pharmacopeial specifications, since the dissolution of both formulations was superior to 80% of the amount declared in the label after 45 minutes of test (A=92.09%±1.84; B=92.84%±1.08). The results obtained indicated that the products A and B are pharmaceutical equivalents. Confidence intervals for the pharmacokinetic parameters were in compliance with the international standards, indicating that products A and B can be considered bioequivalents and, therefore, interchangeable.

;

Downloads

Download data is not yet available.

Downloads

Published

2015-06-01

How to Cite

Serra, C. H. dos R., Chang, K. H., Dezani, T. M., Porta, V., & Storpirtis, S. (2015). Dissolution efficiency and bioequivalence study using urine data from healthy volunteers: a comparison between two tablet formulations of cephalexin. Brazilian Journal of Pharmaceutical Sciences, 51(2), 383-392. https://doi.org/10.1590/S1984-82502015000200016

Issue

Section

Articles